AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Highlights
- Bausch Health announces Health Canada clearance for Solta Medical’s Thermage FLX system.
- Thermage FLX is designed for non-invasive skin tightening and contouring procedures.
- Clearance supports the system's continued expansion within medical aesthetic practices in Canada.
The medical aesthetic sector offers non-surgical technologies for skin enhancement, contouring, and rejuvenation. Used by licensed professionals, these devices meet growing demand for non-invasive treatments. Bausch Health Companies Inc (TSX:BHC) is a key player in this space, drawing interest from investors watching TSX healthcare stock trends.
Thermage FLX System Secures Health Canada Clearance
Solta Medical, a division of Bausch Health Companies Inc., has received official clearance from Health Canada for its Thermage FLX system. This regulatory milestone marks the continued rollout of Thermage FLX in international markets, allowing licensed practitioners in Canada to incorporate the technology into aesthetic treatment offerings. The device is intended for use in non-invasive dermatological procedures involving skin tightening and contouring.
The Thermage FLX system uses radiofrequency technology to stimulate collagen production and improve skin texture. Its design focuses on efficiency and precision, enabling practitioners to perform procedures with minimal downtime for patients. This aligns with ongoing demand in the sector for devices that deliver results without invasive methods.
Technological Framework and Clinical Usage
The system incorporates a combination of advanced radiofrequency delivery and a cooling mechanism to ensure comfort during treatment. A key element of its design is the algorithm-based energy delivery system, which aims to provide consistent results across different treatment areas. Thermage FLX is suitable for use on various parts of the body, including the face, eyes, and abdomen.
Clinicians typically adopt this technology as part of a broader treatment portfolio, integrating it with complementary aesthetic solutions. Its application can be found in settings such as dermatology clinics, plastic surgery centers, and specialized med-spas equipped with regulated devices for aesthetic use.
Regulatory Pathway and Market Accessibility
Clearance from Health Canada is a regulatory requirement for the distribution and clinical application of Class II medical devices in the country. The authorization of Thermage FLX indicates that it meets the regulatory standards for safety and effectiveness under Canadian medical device regulations.
Solta Medical, which has a presence in multiple global markets, continues to expand access to its platform of devices through regional clearances. The addition of Thermage FLX to the Canadian aesthetic device catalog supports the ongoing integration of non-invasive technologies within the country's medical aesthetic sector.
Corporate and Sector Alignment
Bausch Health, through its Solta Medical division, focuses on delivering advanced technologies to practitioners within the aesthetic dermatology landscape. The Thermage FLX system is part of Solta Medical’s broader portfolio, which includes other skin treatment platforms utilized in professional settings.
The aesthetic dermatology sector places emphasis on devices that combine safety, ease of use, and visual results. Thermage FLX aligns with these standards, reinforcing its applicability across varied clinical practices. The clearance underscores the system’s compliance with regulatory benchmarks required for operation in licensed environments in Canada.
